You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
樂普醫療(300003.SZ):擬出資2000萬元參投華夏致遠
格隆匯 07-01 18:20

格隆匯7月1日丨樂普醫療(300003.SZ)公佈,公司擬與專業投資機構華夏股權投資基金管理((北京)有限公司((簡稱(“華夏股權”)及其他有限合夥人簽署(華夏致遠創業投資基金((北京)合夥企業((有限合夥)合夥協議》,投資設立華夏致遠創業投資基金(北京)合夥企業((有限合夥)((具體名稱以工商登記為準,簡稱(“華夏致遠”或“合夥企業”)。基金總認繳出資金額為人民幣3,500萬元,其中公司使用自有資金認繳出資人民幣2,000萬元。華夏致遠設立後,華夏股權為其普通合夥人/執行事務合夥人,並由華夏股權擔任基金管理人。

該基金的投資活動致力於發展Alpha靶向治療的產業鏈,促進其臨牀普及,以期顯著提升有關腫瘤患者的生存狀態和生存期。該基金將主要對分子診斷和靶向治療用生物醫藥及其分子結構或原料、分子診斷和靶向Alpha治療用放射性藥物及其結構或原料以及相關專業服務等全產業鏈的未上市企業進行股權投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account